Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
Introduction Peanut allergy is the the most common cause of life-threatening food-induced anaphylaxis. There is currently no effective long-term treatment. There is a pressing need for definitive treatments that improve the quality of life and prevent fatalities. Allergen oral immunotherapy (OIT) is...
Saved in:
Main Authors: | Michael O’Sullivan, Michael S Gold, Francesca Orsini, Adriana Chebar Lozinsky, Paxton Loke, Susan L. Prescott, Patrick Quinn, Audrey DunnGalvin, Mimi LK Tang, Anne-Louise Ponsoby, Ee Lyn Su, Marnie Robinson, Dean Tey, Kuang-Chih Hsiao, Molly O’Sullivan, Christine Axelrad, Sigrid Pitkin, Jessica Metcalfe, Susan Fahy-Scheer, Thalayasingam Meera, Jovanka King, Fuad Abass, Abigail Cheung, Rachel Wallace, Samara Baldwin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e035871.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current trends in peanut allergy immunotherapy: a review
by: Klementyna Łyżwa, et al.
Published: (2024-04-01) -
Bispecific T-cell engagers in oral cancer immunotherapy
by: Veeraraghavan Vishnu Priya
Published: (2024-06-01) -
Catalysts of change: Immunotherapy's frontier in oral oncology
by: Shyamaladevi Babu, et al.
Published: (2024-09-01) -
Food allergens and oral immunotherapy as indicators
of eosinophilic oesophagitis
by: Andrzej Kuźmiński, et al.
Published: (2024-05-01) -
Targeting autophagy to enhance chemotherapy and immunotherapy in oral cancer
by: Xiaoli Zeng, et al.
Published: (2025-01-01)